HuagongsheHuagongshe Chemistry Print Report · For research reference only
Piperazine → HCID 44609036, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Piperazine | HCID 4837 | — |
| Reactant | Lithium Bromide | HCID 82050 | — |
| Reactant | HCID 66936766 | HCID 66936766 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 44609036 | HCID 44609036 | — |
Reaction Steps
By the same method as in the step d) of Example 45, (3,5-dibromo-4-methoxy-phenyl)-[7-(4-trifluoromethoxy-phenyl)-2,3-dihydro-pyrido[2,3-b][1,4]oxazin-1-yl]-methanone (110 mg, 0.19 mmol), lithium bromide (65 mg, 0.75 mmol) and piperazine (25 mg, 0.29 mmol) were dissolved in N,N-dimethyl formamide (3 ml) and reacted at 100□ to obtain the target compound 66, i.e., (3,5-dibromo-4-hydroxy-phenyl)-[7-(4-trifluoromethoxy-phenyl)-2,3-dihydro-pyrido[2,3-b][1,4]oxazin-1-yl]-methanone, as white solid (54 mg, 48%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08394792B2 |
| Source dataset | uspto-grants-2013_03 |
| ORD ID | ord-339a821ad5214a02b2f1acceca7530fe |
| Source note | uspto-grants-2013_03 |